compstatin
Peptideexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2007 (NCT00473928)
Timeline
Indications
Mechanism of action
- Complement C3INHIBITOR
C3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- al-78898a
- compstatin
- compstatin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01603043 | Phase 2 | Jun 1, 2012 | Alcon |
| NCT01157065 | Phase 2 | Jun 1, 2011 | Alcon |
| NCT00473928 | Phase 1 | May 1, 2007 | Potentia Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alcon | For profit | 2 | 2 | 1 | 2011 |
| Potentia Pharmaceuticals | For profit | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1